KITAGAWA, C., MORI, M., ICHIKI, M., SUKOH, N., KADA, A., SAITO, A. M., & ICHINOSE, Y. (2019). Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer. In Vivo.

KITAGAWA, CHIYOE, MASAHIDE MORI, MASAO ICHIKI, NORIAKI SUKOH, AKIKO KADA, AKIKO M. SAITO, và YUKITO ICHINOSE. "Gefitinib Plus Bevacizumab Vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer." In Vivo 2019.

KITAGAWA, CHIYOE, et al. "Gefitinib Plus Bevacizumab Vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer." In Vivo 2019.